Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SYBXSYNLOGIC, INC.

OTC · CIK 0001527599
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts369

Identity from submissions API

NameSYNLOGIC, INC.
CIK0001527599
TickersSYBX
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN261824804
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-659-2802
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Mirna Therapeutics, Inc. (2011-08-23T04:00:00.000Z → 2017-08-25T04:00:00.000Z)
Business address
PO BOX 30
WINCHESTER
MA
01890
MA
Mailing address
PO BOX 30
WINCHESTER
MA
01890
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

628 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001193125-26-455905 001-37566 261542056 34 7246449 1 1
2026-11-05 425 425 0001193125-26-448753 001-37566 261525078 34 38790
2026-11-02 425 425 0001193125-26-442767 001-37566 261510059 34 27709
2026-08-14 4 4 0001193125-26-352228 16168
2026-08-11 10-Q 10-Q 0001193125-26-344789 001-37566 261263767 34 7180437 1 1
2026-07-29 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000599 005-89131 261219692 34 74647
2026-07-29 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000921895-26-001889 005-89131 261217812 34 11677
2026-07-29 425 425 0001193125-26-322162 001-37566 261213962 34 1185441
2026-07-29 8-K 8-K 1.01,3.03,5.01,7.01,9.01 0001193125-26-322160 001-37566 261213958 34 1602974 1 1
2026-05-18 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000470 001-37566 34 4037
2026-05-14 10-Q 10-Q 0001193125-26-224171 001-37566 26979580 34 5866208 1 1
2026-04-30 10-K/A 10-K/A 0001193125-26-197468 001-37566 26926070 34 2729447 1 1
2026-04-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000921895-26-000926 005-89131 26841385 34 176828
2026-03-12 10-K 10-K 0001193125-26-104262 001-37566 26748237 34 10535426 1 1
2026-01-29 8-K/A 8-K/A 3.01,8.01 0001193125-26-028333 001-37566 26575028 34 173722 1 1
2026-01-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001957912-26-000002 005-89131 26554631 34 17529
2026-01-20 8-K 8-K 3.01 0001193125-26-016040 001-37566 26541268 34 166760 1 1
2025-12-16 8-K 8-K 5.02,5.07,9.01 0001193125-25-319653 001-37566 251573063 34 440430 1 1
2025-11-26 8-K 8-K 3.01 0001193125-25-300824 001-37566 251531555 34 191791 1 1
2025-11-13 10-Q 10-Q 0001193125-25-280270 001-37566 251479087 34 7377610 1 1
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003023 005-89131 251478824 34 6944
2025-11-12 ARS ARS 0001193125-25-277877 001-37566 251473971 34 2320201
2025-11-12 DEF 14A DEF 14A 0001193125-25-277747 001-37566 251473433 34 4276818 1 1
2025-10-31 4 4 0001193125-25-260649 4763
2025-08-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002691 333-289415 251238270 33 1775
2025-08-18 CORRESP filename1.htm 0001193125-25-182671 6459
2025-08-15 S-3/A S-3/A 0001193125-25-181891 333-289415 251224901 33 718622
2025-08-13 UPLOAD filename1.pdf 0000000000-25-008506 333-289415 40062
2025-08-08 S-3 S-3 0001193125-25-176972 333-289415 251198217 33 506444 1 1
2025-08-07 10-Q 10-Q 0000950170-25-105106 001-37566 251194670 34 7738221 1 1
2025-05-08 10-Q 10-Q 0000950170-25-067081 001-37566 25926786 34 6515769 1 1
2025-04-30 10-K/A 10-K/A 0000950170-25-060786 001-37566 25892663 34 3038183 1 1
2025-04-29 4 4 0000950170-25-060267 4899
2025-04-29 4 4 0000950170-25-060253 4843
2025-04-03 4 4 0000950170-25-050478 4776
2025-03-06 10-K 10-K 0000950170-25-034820 001-37566 25715980 34 15436662 1 1
2025-02-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000195 005-89131 25663629 34 6798
2025-02-21 8-K 8-K 5.02 0000950170-25-024891 001-37566 25652402 34 201706 1 1
2025-02-04 4 4 0000950170-25-013831 4781
2025-01-14 8-K 8-K 5.02 0000950170-25-005425 001-37566 25530047 34 199554 1 1
2024-12-23 8-K 8-K 5.02 0000950170-24-139249 001-37566 241569474 34 180155 1 1
2024-12-05 8-K 8-K 5.07,9.01 0000950170-24-133381 001-37566 241527229 34 190495 1 1
2024-11-14 SC 13G/A armistice-sybx093024a1.htm 0001172661-24-005274 005-89131 241463551 34 90445
2024-11-12 S-8 S-8 0001193125-24-256052 333-283165 241449360 33 74386
2024-11-12 S-8 S-8 0001193125-24-256048 333-283164 241449316 33 69112
2024-11-12 10-Q 10-Q 0000950170-24-125567 001-37566 241449158 34 9557196 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125523 001-37566 241448836 34 523199 1 1
2024-11-06 DEF 14A DEF 14A 0001193125-24-251476 001-37566 241429017 34 893459
2024-11-05 ARS ARS 0001193125-24-250921 001-37566 241425428 34 2175633
2024-10-30 4 4 0000950170-24-119194 4694
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093291 001-37566 241185937 34 532104 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093282 001-37566 241185908 34 8019706 1 1
2024-05-16 SC 13D/A NEW ENTERPRISE ASSOCIATES 14, L.P. -- SYNLOGIC, INC. 13D/A(#5) 0001072613-24-000508 005-89131 24957383 34 327901
2024-05-14 10-Q 10-Q 0000950170-24-059064 001-37566 24941365 34 6739494 1 1
2024-05-14 8-K 8-K 2.02,9.01 0000950170-24-059063 001-37566 24941363 34 463294 1 1
2024-04-29 10-K/A 10-K/A 0000950170-24-049810 001-37566 24890425 34 2971792 1 1
2024-04-22 144 xsl144X01/primary_doc.xml 0001972481-24-000103 001-37566 24861335 33 7470
2024-04-18 SC 13G THE SCHEDULE 13G 0000921895-24-000872 005-89131 24853366 34 57449
2024-04-04 4 4 0000950170-24-041790 4781
2024-04-04 4 4 0000950170-24-041787 4807
2024-03-21 3 3 0000950170-24-034867 24279
2024-03-21 4 4 0000950170-24-034866 5302
2024-03-21 3 3 0000950170-24-034859 13573
2024-03-21 8-K 8-K 5.02 0000950170-24-034854 001-37566 24772199 34 212785 1 1
2024-03-21 144 xsl144X01/primary_doc.xml 0001972481-24-000080 001-37566 24771765 33 4376
2024-03-19 10-K 10-K 0000950170-24-033146 001-37566 24761063 34 13441766 1 1
2024-03-19 8-K 8-K 2.02,9.01 0000950170-24-033145 001-37566 24761059 34 487543 1 1
2024-02-22 8-K 8-K 5.02 0001193125-24-042887 001-37566 24665481 34 190987 1 1
2024-02-20 8-A12B 8-A12B 0001193125-24-040093 001-37566 24654687 34 16153
2024-02-20 8-K 8-K 1.01,3.03,5.03,8.01,9.01 0001193125-24-039969 001-37566 24653272 34 470046 1 1
2024-02-16 3 PRIMARY DOCUMENT 0001937147-24-000003 7196
2024-02-16 SC 13D SYBXInitial13D2024.txt 0001937147-24-000001 005-89131 24649071 34 14884
2024-02-14 SC 13G armistice-sybx123123.htm 0001172661-24-001410 005-89131 24637219 34 90635
2024-02-14 SC 13G/A synlogic13gamd2.htm 0000935836-24-000158 005-89131 24634018 34 30724
2024-02-12 8-K 8-K 2.02,2.05,5.02,8.01,9.01 0000950170-24-013803 001-37566 24619738 34 234828 1 1
2024-02-09 SC 13G/A filing.txt 0000315066-24-001488 005-89131 24612066 34 8289
2024-01-04 4 4 0000950170-24-001826 5567
2024-01-04 4 4 0000950170-24-001821 6170
2023-12-29 8-K 8-K 5.02,9.01 0000950170-23-073825 001-37566 231527568 34 320970 1 1
2023-11-17 8-K 8-K 5.02 0000950170-23-064783 001-37566 231418456 34 177281 1 1
2023-11-15 8-K 8-K 5.02 0000950170-23-063906 001-37566 231408528 34 197300 1 1
2023-11-14 4 4 0000950170-23-063927 45625
2023-11-14 4 4 0000950170-23-063926 16512
2023-11-14 4 4 0000950170-23-063925 37527
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061496 001-37566 231389946 34 562061 1 1
2023-11-09 10-Q 10-Q 0000950170-23-061493 001-37566 231389930 34 7431983 1 1
2023-11-07 8-K 8-K 8.01,9.01 0000950170-23-059740 001-37566 231381456 34 552456 1 1
2023-10-13 SC 13D/A NEW ENTERPRISE ASSOCIATES 14, L.P. -- SYNLOGIC, INC. 13D/A(#4) 0001072613-23-000521 005-89131 231325266 34 305273
2023-10-13 SC 13G/A filing.txt 0000315066-23-002702 005-89131 231325062 34 8005
2023-10-06 3 FORM 3 SUBMISSION 0001209191-23-052339 13129
2023-10-04 SC 13D/A AMENDMENT NO. 7 0000947871-23-000977 005-89131 231308318 34 92140
2023-10-02 424B4 424B4 0001193125-23-249173 333-274421 231300542 33 387669
2023-09-29 8-K 8-K 1.01,8.01,9.01 0001193125-23-246542 001-37566 231292149 34 662118 1 1
2023-09-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-09-28 17:00:00 9999999995-23-002818 333-274421 231291633 33 1793
2023-09-28 S-1MEF S-1MEF 0001193125-23-246091 333-274759 231291586 33 81998
2023-09-28 8-K 8-K 5.03,8.01,9.01 0001193125-23-245646 001-37566 231289852 34 187179 1 1
2023-09-28 S-1/A S-1/A 0001193125-23-244819 333-274421 231286269 33 556988
2023-09-27 S-1/A S-1/A 0001193125-23-242769 333-274421 231281679 33 933482
2023-09-26 CORRESP filename1.htm 0001193125-23-242776 6971
2023-09-26 CORRESP filename1.htm 0001193125-23-242772 9601
2023-09-25 UPLOAD filename1.pdf 0000000000-23-010530 39717
2023-09-22 8-K 8-K 5.07 0001193125-23-240503 001-37566 231271887 34 148156 1 1
2023-09-20 CORRESP filename1.htm 0001193125-23-238590 15155
2023-09-15 UPLOAD filename1.pdf 0000000000-23-010208 40341
2023-09-11 UPLOAD filename1.pdf 0000000000-23-010013 42991
2023-09-08 S-1 S-1 0001193125-23-231524 333-274421 231245345 33 523980
2023-09-01 DEF 14A DEF 14A 0001193125-23-226897 001-37566 231230652 34 647859
2023-08-21 PRE 14A PRE 14A 0001193125-23-217065 001-37566 231190011 34 651758
2023-08-16 8-K 8-K 1.01 0001193125-23-214303 001-37566 231178238 34 143524 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040929 001-37566 231157097 34 505034 1 1
2023-08-10 10-Q 10-Q 0000950170-23-040922 001-37566 231157089 34 7629561 1 1
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039666 5573
2023-06-26 4 4 0000950170-23-029809 5354
2023-06-26 4 4 0000950170-23-029808 5202
2023-06-26 4 4 0000950170-23-029805 5225
2023-06-26 4 4 0000950170-23-029804 5229
2023-06-26 4 4 0000950170-23-029802 5262
2023-06-26 4 4 0000950170-23-029797 5223
2023-06-26 4 4 0000950170-23-029787 5814
2023-06-15 8-K 8-K 5.03,5.07,9.01 0001193125-23-167885 001-37566 231017361 34 179503 1 1
2023-06-05 8-K 8-K 2.05,8.01,9.01 0001193125-23-160355 001-37566 23991325 34 177347 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020786 001-37566 23908685 34 499479 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020782 001-37566 23908678 34 6359622 1 1
2023-05-01 ARS ARS 0000950170-23-016339 001-37566 23875226 34 1230279
2023-05-01 DEFA14A DEFA14A 0000950170-23-016336 001-37566 23875181 34 1548909
2023-05-01 DEF 14A DEF 14A 0000950170-23-016333 001-37566 23875095 34 2538928
2023-04-21 PRE 14A PRE 14A 0000950170-23-013828 001-37566 23836242 34 4262495
2023-04-05 4 FORM 4 SUBMISSION 0000899243-23-010715 5588
2023-04-05 4 FORM 4 SUBMISSION 0000899243-23-010716 5417
2023-04-05 4 FORM 4 SUBMISSION 0000899243-23-010714 5632
2023-04-04 424B5 424B5 0001193125-23-090871 333-258151 23797668 33 8276
2023-03-29 S-8 S-8 0001193125-23-083004 333-270926 23771892 33 72749
2023-03-29 S-8 S-8 0001193125-23-082992 333-270925 23771875 33 76427
2023-03-29 8-K 8-K 2.02,9.01 0000950170-23-010430 001-37566 23771692 34 576428 1 1
2023-03-29 10-K 10-K 0000950170-23-010428 001-37566 23771682 34 14941449 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021795 005-89131 23630743 34 75342
2023-02-09 SC 13G/A filing.txt 0000315066-23-002126 005-89131 23605091 34 8145
2023-01-20 SC 13G/A synlogic13gamd1.htm 0000935836-23-000048 005-89131 23539516 34 30426
2023-01-20 SC 13G synlogic13g.htm 0000935836-23-000047 005-89131 23539497 34 30256
2023-01-19 8-K 8-K 8.01,9.01 0001193125-23-010643 001-37566 23535989 34 169305 1 1
2023-01-04 4 FORM 4 SUBMISSION 0000899243-23-000663 6258
2023-01-04 4 FORM 4 SUBMISSION 0000899243-23-000662 5693
2022-12-15 8-K 8-K 8.01,9.01 0001193125-22-305412 001-37566 221463738 34 10316858 1 1
2022-12-09 8-K 8-K 3.01 0001193125-22-301870 001-37566 221455474 34 144715 1 1
2022-11-30 8-K 8-K 2.05,8.01,9.01 0001193125-22-295406 001-37566 221435843 34 197722 1 1
2022-11-23 8-K 8-K 1.01 0000950170-22-025640 001-37566 221412222 34 176179 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024120 001-37566 221374777 34 7506313 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024119 001-37566 221374776 34 672788 1 1
2022-10-18 8-K 8-K 8.01,9.01 0001193125-22-264177 001-37566 221314964 34 10266713 1 1
2022-09-06 8-K 8-K 8.01 0001193125-22-238450 001-37566 221226961 34 143891 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016625 001-37566 221153555 34 778690 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016623 001-37566 221153554 34 7073808 1 1
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036358 5540
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022181 5531
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022180 6143
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022176 5554
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022179 5552
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022178 5591
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022175 5558
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022177 5548
2022-06-13 8-K 8-K 5.07 0001193125-22-172896 001-37566 221011640 34 156112 1 1
2022-05-25 4 FORM 4 SUBMISSION 0000899243-22-019461 4601
2022-05-12 8-K 8-K 2.02,9.01 0001193125-22-148082 001-37566 22915727 34 221746 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019671 001-37566 22915680 34 5948169 1 1
2022-04-27 DEFA14A DEFA14A 0001564590-22-016033 001-37566 22859193 34 1469318
2022-04-27 DEF 14A DEF 14A 0001564590-22-016026 001-37566 22859140 34 799437
2022-04-06 4 FORM 4 SUBMISSION 0000899243-22-014110 5544
2022-04-06 4 FORM 4 SUBMISSION 0000899243-22-014109 5518
2022-03-17 S-8 S-8 0001193125-22-077901 333-263630 22746897 33 80999
2022-03-17 S-8 S-8 0001193125-22-077896 333-263629 22746888 33 87673
2022-03-17 8-K 8-K 2.02,9.01 0001193125-22-077895 001-37566 22746883 34 9137010 1 1
2022-03-17 10-K 10-K 0001564590-22-010714 001-37566 22746618 34 11230399 1 1
2022-03-03 4 FORM 4 SUBMISSION 0000899243-22-009122 7580
2022-03-03 3 FORM 3 SUBMISSION 0000899243-22-009116 6992
2022-03-03 8-K 8-K 5.02,8.01,9.01 0001193125-22-064445 001-37566 22709842 34 280152 1 1
2022-02-09 SC 13G/A filing.txt 0000315066-22-001205 005-89131 22604634 34 8431
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005213 7622
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005207 7599
2022-02-01 4 FORM 4 SUBMISSION 0000899243-22-003838 5695
2022-01-24 8-K 8-K 1.01 0001193125-22-016046 001-37566 22549527 34 144350 1 1
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-000897 6289
2021-11-10 8-K 8-K 2.02,9.01 0001193125-21-325370 001-37566 211394565 34 10380074 1 1
2021-11-10 10-Q 10-Q 0001564590-21-055907 001-37566 211394301 34 7599010 1 1
2021-11-09 8-K 8-K 8.01,9.01 0001193125-21-323850 001-37566 211389977 34 172645 1 1
2021-10-01 SC 13G SC 13G 0001104659-21-122000 005-89131 211299314 34 85549
2021-09-29 SC 13D/A AMENDMENT NO. 6 0000947871-21-001027 005-89131 211292093 34 95009
2021-09-23 8-K 8-K 1.01,8.01,9.01 0001193125-21-280730 001-37566 211272856 34 458167 1 1
2021-09-23 424B5 424B5 0001193125-21-280703 333-258151 211272750 33 515277
2021-09-22 424B5 424B5 0001193125-21-279387 333-258151 211269654 33 516818
2021-09-20 8-K 8-K 7.01,8.01,9.01 0001193125-21-276762 001-37566 211262077 34 30809612 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001193125-21-244019 001-37566 211165868 34 26664925 1 1
2021-08-12 10-Q 10-Q 0001564590-21-043681 001-37566 211165842 34 8383380 1 1
2021-07-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-30 16:01:00 9999999995-21-003011 333-258151 211134488 33 1793
2021-07-30 8-K 8-K 5.02 0001193125-21-231447 001-37566 211132570 34 144432 1 1
2021-07-29 CORRESP filename1.htm 0001193125-21-228388 6855
2021-07-28 UPLOAD filename1.pdf 0000000000-21-009294 40274
2021-07-23 S-3 S-3 0001193125-21-223153 333-258151 211111677 33 1221693
2021-07-15 8-K 8-K 8.01,9.01 0001193125-21-215774 001-37566 211091648 34 170988 1 1
2021-06-17 8-K 8-K 1.01,8.01,9.01 0001193125-21-192697 001-37566 211023365 34 173647 1 1
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040335 5540
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023617 5548
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023616 5554
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023614 5531
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023609 5558
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023606 5552
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023605 5591
2021-06-14 4 FORM 4 SUBMISSION 0000899243-21-023604 6126
2021-06-11 8-K 8-K 5.07 0001193125-21-188984 001-37566 211012128 34 161081 1 1
2021-05-13 8-K 8-K 2.02,9.01 0001193125-21-159793 001-37566 21917124 34 246805 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027177 001-37566 21917026 34 6612027 1 1
2021-05-10 SC 13G filing.txt 0000315066-21-001544 005-89131 21906063 34 8366
2021-05-05 8-K 8-K 1.01 0001193125-21-151700 001-37566 21893216 34 146455 1 1
2021-04-27 DEFA14A DEFA14A 0001564590-21-020917 001-37566 21859382 34 271569
2021-04-27 DEF 14A DEF 14A 0001564590-21-020875 001-37566 21858830 34 818571
2021-04-22 4 xslF345X03/ownership.xml 0000947871-21-000455 8567
2021-04-22 4 xslF345X03/ownership.xml 0000947871-21-000454 6542
2021-04-22 SC 13D/A AMENDMENT NO. 5 0000947871-21-000453 005-89131 21845517 34 105709
2021-04-19 424B5 424B5 0001193125-21-121228 333-226730 21834633 33 510309
2021-04-16 8-K 8-K 1.01,8.01,9.01 0001193125-21-118562 001-37566 21830177 34 444005 1 1
2021-04-15 424B5 424B5 0001193125-21-117780 333-226730 21828721 33 526476
2021-04-14 8-K 8-K 8.01,9.01 0001564590-21-018749 001-37566 21824167 34 197153 1 1
2021-03-29 SC 13D/A AMENDMENT 4 0000947871-21-000398 005-89131 21781962 34 74670
2021-03-25 S-8 S-8 0001193125-21-093473 333-254689 21770183 33 69820
2021-03-25 S-8 S-8 0001193125-21-093470 333-254688 21770176 33 70519
2021-03-25 8-K 8-K 2.02,9.01 0001564590-21-015273 001-37566 21770148 34 26121641 1 1
2021-03-25 10-K 10-K 0001564590-21-015256 001-37566 21770075 34 11901946 1 1
2021-03-24 8-K 8-K 7.01,9.01 0001564590-21-015132 001-37566 21768881 34 191240 1 1
2021-03-12 4 FORM 4 SUBMISSION 0000899243-21-011336 7612
2021-03-12 4 FORM 4 SUBMISSION 0000899243-21-011334 7642
2021-03-12 4 FORM 4 SUBMISSION 0000899243-21-011332 7610
2021-03-08 8-K 8-K 2.02,9.01 0001564590-21-011355 001-37566 21720604 34 1452871 1 1
2021-02-11 4 FORM 4 SUBMISSION 0000899243-21-005927 5488
2021-02-11 3 FORM 3 SUBMISSION 0000899243-21-005921 2973
2021-02-10 424B5 424B5 0001193125-21-036277 333-226730 21613962 33 30850
2021-02-10 8-K 8-K 5.02,9.01 0001564590-21-005146 001-37566 21609499 34 1752453 1 1
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-001076 6316
2020-12-14 8-K 8-K 2.02,9.01 0001564590-20-056927 001-37566 201384984 34 191782 1 1
2020-12-10 8-K 8-K 5.02,9.01 0001564590-20-056594 001-37566 201378790 34 224701 1 1
2020-12-09 4 FORM 4 SUBMISSION 0000899243-20-033178 5515
2020-12-09 3 FORM 3 SUBMISSION 0000899243-20-033175 3000
2020-11-05 8-K 8-K 2.02,9.01 0001564590-20-050819 001-37566 201288527 34 6950691 1 1
2020-11-05 10-Q 10-Q 0001564590-20-050817 001-37566 201288524 34 7290596 1 1
2020-08-10 3 FORM 3 SUBMISSION 0000899243-20-021872 11993
2020-08-06 10-Q 10-Q 0001564590-20-037234 001-37566 201079772 34 7114953 1 1
2020-08-06 8-K 8-K 2.02,9.01 0001564590-20-037226 001-37566 201079730 34 6673251
2020-07-28 4 FORM 4 SUBMISSION 0000899243-20-020582 6164
2020-07-28 4 FORM 4 SUBMISSION 0000899243-20-020581 6274
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015650 5571
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035035 5539
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015649 5577
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015648 5570
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015647 5573
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015645 5556
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015644 6150
2020-06-04 8-K 8-K 5.07 0001193125-20-160715 001-37566 20943128 34 23832
2020-05-27 8-K 8-K 7.01,9.01 0001564590-20-026938 001-37566 20912798 34 45909
2020-05-21 8-K 8-K 1.02,9.01 0001564590-20-026438 001-37566 20899948 34 50946
2020-05-08 10-Q 10-Q 0001564590-20-023231 001-37566 20858652 34 5464560 1
2020-05-08 8-K 8-K 2.02,9.01 0001564590-20-023232 001-37566 20858649 34 106775
2020-04-17 DEFA14A DEFA14A 0001564590-20-017260 001-37566 20799818 34 376062
2020-04-17 DEF 14A DEF 14A 0001564590-20-017249 001-37566 20799651 34 731351
2020-03-31 8-K 8-K 8.01,9.01 0001564590-20-014576 001-37566 20762677 34 57045
2020-03-18 424B5 424B5 0001193125-20-077215 333-226730 20725169 33 7870
2020-03-12 4 FORM 4 SUBMISSION 0000899243-20-008100 7544
2020-03-12 4 FORM 4 SUBMISSION 0000899243-20-008099 7573
2020-03-12 8-K 8-K 2.02,9.01 0001564590-20-010513 001-37566 20709510 34 110834
2020-03-12 S-8 S-8 0001193125-20-071060 333-237105 20707410 33 66238
2020-03-12 S-8 S-8 0001193125-20-071058 333-237104 20707404 33 67018
2020-03-12 10-K 10-K 0001564590-20-010261 001-37566 20707377 34 9833824 1
2020-02-14 SC 13G/A sybx_13gv3.htm 0001591986-20-000004 005-89131 20613074 34 59768
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002806 5501
2020-02-04 3 FORM 3 SUBMISSION 0000899243-20-002803 6880
2020-01-31 8-K 8-K 5.02,9.01 0001193125-20-021342 001-37566 20565278 34 63281
2020-01-07 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000001 005-89131 20512290 34 32955
2020-01-02 4 FORM 4 SUBMISSION 0000899243-20-000021 5674
2019-12-20 8-K 8-K 5.02,9.01 0001193125-19-321039 001-37566 191302137 34 84882
2019-12-16 4 FORM 4 SUBMISSION 0000899243-19-029298 4569
2019-12-09 SC 13G/A SEC SCHEDULE 13G 0000902219-19-000484 005-89131 191274594 34 37438
2019-11-12 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-19-002255 001-37566 191209606 34 111432
2019-11-12 10-Q 10-Q 0001564590-19-042635 001-37566 191206404 34 7446045 1
2019-10-24 4 FORM 4 SUBMISSION 0000899243-19-025927 5663
2019-10-24 3 FORM 3 SUBMISSION 0000899243-19-025925 6838
2019-10-24 8-K 8-K 5.02,9.01 0001193125-19-273622 001-37566 191166701 34 71134
2019-09-25 4 FORM 4 SUBMISSION 0000899243-19-024251 5051
2019-09-25 4 FORM 4 SUBMISSION 0000899243-19-024249 5053
2019-09-25 4 FORM 4 SUBMISSION 0000899243-19-024248 5075
2019-09-18 3 FORM 3 SUBMISSION 0000899243-19-023827 6890
2019-09-17 424B3 424B3 0001193125-19-246866 333-233139 191097312 33 114942
2019-09-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-09-13 16:00:00 9999999995-19-002090 333-233139 191093581 33 1793
2019-09-11 CORRESP filename1.htm 0001193125-19-242965 8811
2019-09-04 8-K SYNLOGIC, INC. 8-K 5.02,9.01 0001157523-19-001946 001-37566 191074614 34 25766
2019-08-30 CORRESP filename1.htm 0001193125-19-235328 26090
2019-08-30 S-3/A S-3/A 0001193125-19-235325 333-233139 191069831 33 184312
2019-08-20 UPLOAD filename1.pdf 0000000000-19-012674 44642
2019-08-20 8-K SYNLOGIC, INC. 8-K 7.01,8.01,9.01 0001157523-19-001887 001-37566 191037816 34 6487139
2019-08-13 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-19-001827 001-37566 191018252 34 5628188
2019-08-12 SC 13D/A AMENDMENT NO. 3 0000947871-19-000579 005-89131 191017454 34 117866
2019-08-08 S-3 S-3 0001193125-19-216936 333-233139 191010227 33 194867
2019-08-08 10-Q 10-Q 0001564590-19-030838 001-37566 191010022 34 7720221 1
2019-08-08 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-19-001783 001-37566 191010005 34 102082
2019-07-15 8-K SYNLOGIC, INC. 8-K 7.01,8.01,9.01 0001157523-19-001521 001-37566 19954042 34 1254995
2019-07-01 4 FORM 4 SUBMISSION 0000899243-19-018631 5657
2019-06-21 3 PRIMARY DOCUMENT 0000904454-19-000519 10562
2019-06-21 SC 13G SCHEDULE 13G FOR SYNLOGIC, INC. BY GINKGO BIOWORKS, INC. 0000904454-19-000517 005-89131 19912082 34 45469
2019-06-18 D xslFormDX01/primary_doc.xml 06b 0001777547-19-000002 021-342188 19903103 33 12744
2019-06-12 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001193125-19-170721 001-37566 19892411 34 16141720
2019-06-07 4 FORM 4 SUBMISSION 0001209191-19-035601 5547
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015998 5574
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015997 5582
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015996 6168
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015995 5551
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015994 5588
2019-06-07 4 FORM 4 SUBMISSION 0000899243-19-015993 5595
2019-06-05 8-K FORM 8-K 5.07 0001193125-19-166110 001-37566 19879791 34 24688
2019-05-09 10-Q 10-Q 0001564590-19-018049 001-37566 19811059 34 6364917 1
2019-05-09 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-19-001184 001-37566 19811029 34 1510743
2019-05-07 3 FORM 3 SUBMISSION 0000899243-19-012594 6883
2019-04-23 CT ORDER filename1.pdf 20190423,20190423 9999999997-19-003244 001-37566 19762001 34 90385
2019-04-18 DEF 14A DEF 14A 0001193125-19-109983 001-37566 19754647 34 432924
2019-04-09 4 FORM 4 SUBMISSION 0000899243-19-010393 6258
2019-03-20 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-19-000656 001-37566 19693653 34 7129403
2019-03-12 S-8 S-8 0001193125-19-071992 333-230224 19676950 33 67866
2019-03-12 10-K 10-K 0001564590-19-007367 001-37566 19675499 34 13259252 1
2019-03-12 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-19-000583 001-37566 19673942 34 73010
2019-03-07 8-K FORM 8-K 5.02 0001193125-19-067277 001-37566 19666225 34 16528
2019-03-06 4 FORM 4 SUBMISSION 0000899243-19-006432 5624
2019-03-06 4 FORM 4 SUBMISSION 0000899243-19-006431 5605
2019-02-14 4 FORM 4 SUBMISSION 0000899243-19-003603 6422
2019-02-14 SC 13G v2136482sybx.htm 0001591986-19-000002 005-89131 19604868 34 72298
2019-02-12 4 FORM 4 SUBMISSION 0000899243-19-003342 5499
2019-02-12 3 FORM 3 SUBMISSION 0000899243-19-003339 6825
2019-02-12 SC 13G/A e618194_sc13ga-synolgic.htm 0001193805-19-000205 005-89131 19591101 34 131927
2019-02-12 SC 13G/A SEC SCHEDULE 13G 0000846087-19-000050 005-89131 19588551 34 18874
2019-02-12 SC 13G/A SEC SCHEDULE 13G 0000902219-19-000255 005-89131 19588270 34 37456
2019-02-12 8-K SYNLOGIC, INC. 8-K 5.02,9.01 0001157523-19-000296 001-37566 19587614 34 30876
2019-01-07 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-19-000033 001-37566 19512130 34 7441479
2018-12-20 CT ORDER filename1.pdf 20181220,20181220 9999999997-18-009631 001-37566 181246052 34 105234
2018-12-18 8-K FORM 8-K 5.02 0001193125-18-352099 001-37566 181240680 34 17891
2018-12-12 8-K SYNLOGIC, INC. 8-K 1.01,8.01,9.01 0001157523-18-002562 001-37566 181230007 34 30760
2018-11-19 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-18-002452 001-37566 181191218 34 6864347
2018-11-13 10-Q 10-Q 0001564590-18-029326 001-37566 181178433 34 5576433 1
2018-11-13 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-18-002420 001-37566 181178412 34 63329
2018-11-13 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-18-002409 001-37566 181174996 34 12579804
2018-11-01 4 FORM 4 SUBMISSION 0000899243-18-027889 5656
2018-10-19 4 FORM 4 SUBMISSION 0000899243-18-027071 5100
2018-10-04 8-K FORM 8-K 5.02,9.01 0001193125-18-293271 001-37566 181107992 34 38256
2018-09-19 4 FORM 4 SUBMISSION 0000899243-18-024753 5103
2018-09-07 4 FORM 4 SUBMISSION 0000899243-18-023995 5104
2018-09-05 8-K SYNLOGIC, INC. 8-K 7.01,9.01 0001157523-18-001910 001-37566 181053851 34 5560581
2018-09-04 8-K SYNLOGIC, INC. 8-K 7.01,8.01,9.01 0001157523-18-001898 001-37566 181051148 34 2266128
2018-08-31 4 FORM 4 SUBMISSION 0000899243-18-023638 6901
2018-08-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-08-30 16:00:00 9999999995-18-002248 333-226730 181048407 33 1793
2018-08-28 CORRESP filename1.htm 0001193125-18-260576 9523
2018-08-23 CORRESP filename1.htm 0001193125-18-256326 18487
2018-08-23 S-3/A S-3/A 0001193125-18-256311 333-226730 181034946 33 440925
2018-08-20 UPLOAD filename1.pdf 0000000000-18-025658 48073
2018-08-09 S-3 S-3 0001193125-18-244428 333-226730 181005565 33 2460286
2018-08-09 10-Q 10-Q 0001564590-18-020755 001-37566 181003470 34 5686478 1
2018-08-08 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-18-001772 001-37566 181001527 34 60410
2018-07-19 4 FORM 4 SUBMISSION 0000899243-18-020190 5103
2018-06-21 4 FORM 4 SUBMISSION 0000899243-18-017588 7982
2018-06-14 4 FORM 4 SUBMISSION 0001209191-18-037734 5547
2018-06-14 4 FORM 4 SUBMISSION 0000899243-18-016593 5568
2018-06-14 4 FORM 4 SUBMISSION 0000899243-18-016592 6162
2018-06-14 4 FORM 4 SUBMISSION 0000899243-18-016591 5545
2018-06-14 4 FORM 4 SUBMISSION 0000899243-18-016590 5589
2018-06-14 4 FORM 4 SUBMISSION 0000899243-18-016589 5582
2018-06-13 8-K 8-K 5.07 0001193125-18-191625 001-37566 18896774 34 20254
2018-06-06 4 FORM 4 SUBMISSION 0000899243-18-015255 5622
2018-06-06 8-K FORM 8-K 5.02 0001193125-18-185780 001-37566 18884535 34 17451
2018-05-15 DEFA14A DEFA14A 0001193125-18-164186 001-37566 18837179 34 21308
2018-05-15 10-Q 10-Q 0001564590-18-013629 001-37566 18836419 34 5455146 1
2018-05-15 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-18-001118 001-37566 18833033 34 55119
2018-05-10 SC 13G SEC SCHEDULE 13G 0000902219-18-000452 005-89131 18821009 34 37496
2018-04-27 DEF 14A DEF 14A 0001193125-18-136540 001-37566 18780877 34 1269553
2018-04-16 SC 13G SEC SCHEDULE 13G 0001645257-18-000004 005-89131 18755622 34 18857
2018-04-12 SC 13D/A AMENDMENT NO. 2 0000947871-18-000334 005-89131 18751534 34 135420
2018-04-06 424B5 424B5 0001193125-18-110119 333-220948 18743789 33 409373
2018-04-06 8-K FORM 8-K 1.01,9.01 0001193125-18-109307 001-37566 18741957 34 239513
2018-03-20 S-8 S-8 0001193125-18-089307 333-223798 18702562 33 68264
2018-03-20 10-K 10-K 0001564590-18-006323 001-37566 18702100 34 14440857 1
2018-03-20 8-K SYNLOGIC, INC. 8-K 2.02,9.01 0001157523-18-000596 001-37566 18701971 34 85574
2018-03-16 4 FORM 4 SUBMISSION 0000899243-18-007675 5742
2018-03-15 4 FORM 4 SUBMISSION 0000899243-18-007539 5607
2018-03-15 4 FORM 4 SUBMISSION 0000899243-18-007530 5573
2018-03-15 4 FORM 4 SUBMISSION 0000899243-18-007529 5566
2018-03-15 4 FORM 4 SUBMISSION 0000899243-18-007528 5588
2018-02-14 SC 13D/A SC 13D/A 0001144204-18-008574 005-89131 18610167 34 103614
2018-02-13 SC 13G/A SCHEDULE 13G AMENDMENT 2 0000078003-18-000014 005-89131 18604604 34 28207
2018-02-13 5 FORM 5 SUBMISSION 0000899243-18-003687 5832
2018-02-09 SC 13G/A sc13ga.htm 0001493152-18-001744 005-89131 18592208 34 172145
2018-02-05 SC 13G/A synl17a2.htm 0000038777-18-000027 005-89131 18574062 34 195615
2018-02-01 SC 13D/A NEW ENTERPRISE ASSOCIATES 14, L.P. - SYNLOGIC, INC. 13DA (#3) 0001072613-18-000066 005-89131 18565939 34 387548
2018-01-30 4 FORM 4 SUBMISSION 0000899243-18-002261 5269
2018-01-30 4 FORM 4 SUBMISSION 0000899243-18-002260 6223
2018-01-30 4 FORM 4 SUBMISSION 0000899243-18-002259 7903
2018-01-29 SC 13G/A e617606_sc13ga-synolgic.htm 0001193805-18-000073 005-89131 18555086 34 129172
2018-01-26 SC 13D/A AMENDMENT NO. 1 0000947871-18-000070 005-89131 18552939 34 171309
2018-01-26 4 FORM 4 SUBMISSION 0001209191-18-005631 5285
2018-01-26 4 FORM 4 SUBMISSION 0001209191-18-005630 5251

Latest XBRL company facts

One latest value per concept from companyfacts (369 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 12.25M 2026-11-03 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
dei EntityNumberOfEmployees Entity Number of Employees employee 4 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
dei EntityPublicFloat Entity Public Float USD 4.40M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197468
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 501,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.50M 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024120
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 56,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 14.28M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224171
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 156.69M 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 459.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 3.05M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 22.87M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015256
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 800,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125567
us-gaap Assets Assets USD 11.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AssetsCurrent Assets, Current USD 11.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 5,000 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1,000 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 23.78M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 98.62M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 7,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax USD -4,000 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 118,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 98.73M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 17,000 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 99.00M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020755
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 98.62M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 23.79M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 8.04M 2021-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year Investment 0 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020755
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year Investment 27 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020755
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 400,000 2016-09-30 2016 Q3 10-Q 2016-11-10 0001527599-16-000007
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 278 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 266,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 210,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 503,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 287,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 2,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 214,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 27,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 476,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap Cash Cash USD 79.17M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 11.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 18.86M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.21M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 11.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 28.28M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 11.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -31.25M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 1.10M 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015256
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 14.70M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 64.59M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.7 2026-07-27 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 7.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 12.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 12.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonStockValue Common Stock, Value, Issued USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap CommonUnitIssuanceValue Common Unit, Issuance Value USD 592,000 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap CommonUnitIssued Common Unit, Issued shares 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 465,000 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-018049
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 33,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 33,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Investment 0 2023-12-31 2024 Q3 10-Q 2024-11-12 0000950170-24-125567
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Investment 31 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029326
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 5.40M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Investment 28 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024120
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 92,000 2014-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap DeferredRentCredit Deferred Rent Credit USD 200,000 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 393,000 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 7.69M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 434,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 668,000 2017-12-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 867,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 134.28M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 108.89M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 64,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 10.93M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 210,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 2.21M 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 134.28M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 241,000 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 0 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.72M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015256
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2021-01-01 2021-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2021-01-01 2021-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.06 2021-01-01 2021-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap Depreciation Depreciation USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.98M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050817
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 18,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 783,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344789
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap DistributedEarnings Distributed Earnings USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2007-12-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.22 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019671
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.143 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.27 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.104 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 200,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -539,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 339,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 21,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 210,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 216,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 214,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 2,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 2,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 72,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 6,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 900,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 188,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.061 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 80,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 80,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ImpairmentChargeOnReclassifiedAssets Impairment Charge on Reclassified Assets USD 800,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ImpairmentLossesRelatedToRealEstatePartnerships Impairment Losses Related to Real Estate Partnerships USD 5.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxesPaid Income Taxes Paid USD 11,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -142,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 10.81M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -209,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 103,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -314,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 653,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061493
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -4.80M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 1.27M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -354,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -490,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 1.05M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 2.43M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001527599-16-000007
us-gaap InterestExpense Interest Expense USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093282
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 14,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 182,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 360,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 0 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1.75M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.50M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap LeaseCost Lease, Cost USD 4.97M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 9.50M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 20.36M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.98M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.67M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.02M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.90M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.79M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.00M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3.09M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap Liabilities Liabilities USD 1.42M 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 11.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 1.00M 2017-07-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap LossOnContractTerminationForDefault Loss on Contract Termination for Default USD 0 2015-07-01 2015-07-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 7.50M 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001558370-16-007977
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 689,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001527599-17-000012
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 53.64M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -71.87M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -13.03M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NetIncomeLossAllocatedToLimitedPartners Net Income (Loss) Allocated to Limited Partners USD -14.11M 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 4.98M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001527599-17-000012
us-gaap NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax USD/shares -4.49 2017-01-01 2017-03-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap NonoperatingGainsLosses Nonoperating Gains (Losses) USD -138,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001527599-16-000007
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 899,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OperatingExpenses Operating Expenses USD 4.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.58M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 17.27M 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 34.92M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.17M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 3.57M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 3.47M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 3.37M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 3.27M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 18.07M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 450,929 2017-03-31 2017 Q1 10-Q 2017-05-09 0001527599-17-000012
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 401.80M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 31,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OtherAssetsCurrent Other Assets, Current USD 35,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -38,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029326
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -4,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -9,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 131,000 2020-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010714
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 5,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 23,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 2.48M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006323
us-gaap PaymentsForProceedsFromBusinessesAndInterestInAffiliates Payments for (Proceeds from) Businesses and Interest in Affiliates USD -40.43M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap PaymentsForRestructuring Payments for Restructuring USD 5.27M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 6.60M 2018-01-01 2018-01-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 226,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001558370-15-002653
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 114.98M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020755
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 79.79M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001527599-16-000007
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap PreferredStockDividendsPerShareCashPaid Preferred Stock, Dividends, Per Share, Cash Paid USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2024-02-20 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 239,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 10.53M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042635
us-gaap PrepaidInsurance Prepaid Insurance USD 181,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 40.43M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap ProceedsFromIssuanceOfPreferredLimitedPartnersUnits Proceeds from Issuance of Preferred Limited Partners Units USD 26.65M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 40.43M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029326
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 22.87M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015256
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 244,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010261
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 19.89M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 427,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007367
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 49,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224171
us-gaap RestrictedCash Restricted Cash USD 50,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 50,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -73,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024120
us-gaap RestructuringCharges Restructuring Charges USD 1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap RestructuringCosts Restructuring Costs USD 2.72M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap RestructuringReserve Restructuring Reserve USD 111,000 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 79,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.61M 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 1.10M 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD 200,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 5.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -446.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap SeveranceCosts1 Severance Costs USD 240,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.12 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-280270
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 1.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 554,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.87M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.7 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 302,040 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 5.46 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 680,330 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.15 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.44M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.54M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.23 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 200,000 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 5.24 2017-06-30 2017 Q2 10-Q 2017-08-04 0001527599-17-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 1.44M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 4.54M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.23 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.26 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.41 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.2 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125567
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 12 2024-02-20 2025 Q3 10-Q 2025-11-13 0001193125-25-280270
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 330,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015256
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 10.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.14 2017-08-25 2018 Q2 10-Q 2018-08-09 0001564590-18-020755
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 135,684 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055907
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 100.94M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 124,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.25M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061493
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 1,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0000950170-23-010428
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 1.85 2023-11-09 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 41,819 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 2.52M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 1.22M 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-340965
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033146
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 106,000 2015-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001527599-17-000004
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2015-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2015-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2015-12-31 2015 FY 10-K 2016-03-30 0001558370-16-004457
us-gaap TreasuryStockShares Treasury Stock, Shares shares 4.20M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020782
us-gaap TreasuryStockValue Treasury Stock, Value USD 2.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 153,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104262
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.09M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034820
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD 2.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 12.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905
us-gaap WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted Weighted Average Number of Limited Partnership and General Partnership Unit Outstanding, Basic and Diluted shares 1.64M 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013629
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 71.97M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019671
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 12.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-455905

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →